Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | +6.00% | +55.88% | -20.60% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.60% | 2.64M | |
+8.80% | 105B | |
-0.78% | 104B | |
+5.79% | 22.94B | |
-12.31% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.78% | 16.96B | |
+8.21% | 14.16B | |
+39.60% | 12.63B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Earnings Flash (CYCC) CYCLACEL Reports Q3 Revenue $16,000